Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00799682

Recruitment Status : Completed

First Posted : December 1, 2008

Last Update Posted : July 21, 2011

Sponsor:

Collaborator:

Pfizer

Information provided by:

Ophthalmic Consultants of Long Island

Results Submitted - Not Posted on ClinicalTrials.gov

Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.

Recruitment Status :	Completed
Actual Primary Completion Date :	January 2011
Actual Study Completion Date :	February 2011

Submission Cycle	Results Submitted to ClinicalTrials.gov	Results Returned after Quality Control Review
1	August 21, 2018	September 17, 2018

To Top